Tata Elxsi Q2 revenue up 15% to Rs 1,056 crore; shares rise over 7%
Representative image: Pexels / Pixabay
Tata Elxsi's Q2 FY27 revenue rose 15% to Rs 1,055.66 crore and profit about 10% to Rs 170.30 crore; shares rose over 7% on October 14, 2026.
What Happened
Tata Elxsi, the design and technology services company of the Tata group, reported revenue from operations of Rs 1,055.66 crore for the September quarter of 2026, up 15% from Rs 918.10 crore a year earlier and 3.4% higher than the previous quarter. Net profit for the quarter, announced on Tuesday, October 13, 2026, was Rs 170.30 crore, up about 10% from Rs 154.82 crore a year ago but roughly flat compared with the June quarter. The company said growth was broad-based across its three main businesses: transportation, media and communications, and healthcare and life sciences. Its shares rose more than 7% in trade on Wednesday, October 14, as investors reacted to the results.
Key Facts
- Revenue from operations: Rs 1,055.66 crore in Q2 FY27, up 15% year on year and 3.4% quarter on quarter; constant-currency growth was 2.3% sequentially.
- Net profit: Rs 170.30 crore, up about 10% year on year from Rs 154.82 crore, and roughly flat against Rs 170.6 crore in Q1.
- EBITDA: Rs 231.4 crore, up 7.1% from the previous quarter, with an EBITDA margin of 21.9%.
- Segment growth in constant currency, quarter on quarter: transportation 2%, media and communications 3.4%, healthcare and life sciences 3.5%.
- Management expects the second half of the year to be better than the first, led by healthcare and life sciences, while flagging a slow automotive sector in Europe, according to reports.
- Shares rose over 7% intraday on October 14, 2026.
Why It Matters
Tata Elxsi is not a typical IT outsourcing company. Its three main businesses serve transportation, media and communications, and healthcare and life sciences clients, which makes it a useful gauge of how much global companies are spending on new products rather than routine IT. Its transportation business serves car makers, including in Europe, which is why the management's comment on a slow European automotive sector matters.
The quarter shows a company growing steadily but not quickly. Revenue rose 15% over the year, yet profit grew more slowly and was flat compared with the June quarter, and one market tracker said profit missed analysts' estimates. Growth in healthcare and life sciences, which management expects to lead the second half, is becoming more important as automotive work slows.
For investors, the share-price jump suggests relief that results were not worse after a difficult period for the sector, and it came a day after a broad rally in Indian technology stocks. Whether the gains hold will depend on the second-half recovery that management has promised.
| Measure | Q2 FY26 | Q2 FY27 |
|---|---|---|
| Revenue from operations | Rs 918.10 crore | Rs 1,055.66 crore |
| Net profit | Rs 154.82 crore | Rs 170.30 crore |
| EBITDA margin (Q2 FY27) | - | 21.9% |
Impact
Short-term: The results and share rally improve sentiment towards engineering-services companies, although analysts will watch whether automotive demand in Europe weakens further.
Long-term: A shift towards healthcare and media work could make Tata Elxsi less dependent on car makers, while any recovery in automotive design spending would lift its largest business.
Who is affected: Tata Elxsi's shareholders and employees, its clients in automotive, media and healthcare, and investors in India's engineering research and development services sector.
Key Takeaway
Tata Elxsi grew revenue 15% in the September quarter but profit was flat sequentially, and it is counting on healthcare and a better second half while European car demand stays slow.
Questions and Answers
What were Tata Elxsi's Q2 FY27 results?
Revenue from operations rose 15% year on year to Rs 1,055.66 crore and net profit rose about 10% to Rs 170.30 crore, though profit was roughly flat compared with the previous quarter.
How did Tata Elxsi shares react?
The shares rose more than 7% in intraday trade on October 14, 2026, a day after the results.
Which business grew fastest?
Healthcare and life sciences grew 3.5% quarter on quarter in constant currency, slightly ahead of media and communications at 3.4% and transportation at 2%.
What is the outlook?
Management expects the second half of FY27 to be better than the first, led by healthcare and life sciences, while flagging slow automotive demand in Europe.
Disclaimer: Prepared by the Peepals newsroom from publicly available sources with AI assistance. Information is accurate to the best of our knowledge at the time of publication and may change. Images may be representative. Not professional advice. Report an error via our contact page.
Sourced and fact-checked by the Peepals Global Editorial Team
StockGro parent approves Rs 536 crore fresh issue for IPO, adds independent directors
Wholesale inflation jumps to 11.39% in September as fuel, food and metals rise
Reported, fact-checked and published by the Peepals Global Editorial Team.
